Compare Stocks → CBOE shift unlocks new weekend income strategy (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison TSE:HSMNYSEARCA:IPD Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSMHelius Medical TechnologiesC$18.35C$14.26▼C$40.00C$42.54MN/A3,578 shs930 shsIPDSPDR S&P International Consumer$39.92$0.00$34.36▼$42.84N/AN/A5,198 shsN/AThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSMHelius Medical Technologies0.00%0.00%0.00%0.00%0.00%IPDSPDR S&P International Consumer0.00%0.00%0.00%0.00%0.00%Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSMHelius Medical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AIPDSPDR S&P International ConsumerN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSMHelius Medical TechnologiesN/AN/AN/AN/AIPDSPDR S&P International ConsumerN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSMHelius Medical TechnologiesC$477K0.00N/A5.71C$3.61 per share0.00IPDSPDR S&P International ConsumerN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSMHelius Medical TechnologiesN/A-C$11.02N/AN/AN/AN/AN/AN/AN/AIPDSPDR S&P International ConsumerN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSMHelius Medical TechnologiesN/AN/AN/AN/AN/AIPDSPDR S&P International Consumer$0.761.90%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSMHelius Medical Technologies0.744.203.58IPDSPDR S&P International ConsumerN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSMHelius Medical TechnologiesN/AIPDSPDR S&P International ConsumerN/AInsider OwnershipCompanyInsider OwnershipHSMHelius Medical TechnologiesN/AIPDSPDR S&P International ConsumerN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableHSMHelius Medical Technologies192.32 millionN/ANot OptionableIPDSPDR S&P International ConsumerN/AN/AN/ANot OptionableLBT, IPD, OVN, HSM, and UBI HeadlinesSourceHeadlineS&P Global: Rebounding From Weak Ratings Businessmsn.com - September 4 at 10:06 AMMedia Sentiment Over TimeCompany DescriptionsHelius Medical TechnologiesTSE:HSMHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.SPDR S&P International ConsumerNYSEARCA:IPDSPDR S&P International Consumer Discretionary Sector ETF (the Fund) seeks to provide investment results that correspond generally to the total return performance of the S&P Developed Ex-U.S. BMI Consumer Discretionary Sector Index (the Index), an index that tracks the consumer discretionary sector of developed global markets outside the United States. The Index represents the non-United States consumer discretionary sub-industry of developed countries included in the S&P Broad Market Index (the Global BMI Index). The Global BMI Index captures the full universe of institutionally investable stocks in developed and emerging markets with float-adjusted market capitalizations of at lease $100 million. The Fund's investment advisor is SSgA Funds Management, Inc. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.